NCT03604250 (JANUS) is a NA clinical trial of Lifestyle plus prebiotic supplement in Metabolic Syndrome, sponsored by January, Inc..

Who is sponsoring NCT03604250?

NCT03604250 is sponsored by January, Inc..

What drugs are being tested in NCT03604250?

Interventions in NCT03604250: Lifestyle plus prebiotic supplement.

What condition does NCT03604250 study?

NCT03604250 studies Metabolic Syndrome.

Is NCT03604250 still recruiting?

NCT03604250 is currently suspended. Last updated 9 June 2020.

Last reviewed 2020-06-09 · How we verify

NCT03604250: JANUS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The January Application NUtritional Study (JANUS)

Suspended NA Last updated 9 June 2020

What this trial tests

NA trial testing Lifestyle plus prebiotic supplement in Metabolic Syndrome in 14 participants. Suspended.

Timeline

1 May 2021

Primary endpoint
1 October 2021

1 October 2021

Quick facts

Lead sponsor	January, Inc.
Phase	NA
Status	Suspended
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	14
Start date	1 May 2021
Primary completion	1 October 2021
Estimated completion	1 October 2021
Sites	1 location across United States

Drugs / interventions tested

Lifestyle plus prebiotic supplement

Conditions studied

Metabolic Syndrome — all drugs for Metabolic Syndrome →

Sponsor

January, Inc.

Who can join

Adults 30 to 60, any sex, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Human beings react differently to changes in diet, exercise, and sleep patterns. The goal of this study is to (1) learn how individuals react to lifestyle choices and suggestions by examining a small group of people with similar health and lifestyle profiles; and (2) to develop algorithmic policies (male/female) that will help people optimize their health through lifestyle interventions and supplementation with prebiotics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03604250 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by January, Inc.
Last refreshed: 9 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03604250.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing